Protein and lipid quantification, determining protein activity and oxidized lipids, inflammatory marker analyses.
Development and characterization of biomaterials for a wide variety of anterior ocular applications.
Connecting the dots between the day-to-day wearing experience, clinical signs and the characteristics of contemporary and future lens materials and solutions.
Investigating the anterior eye’s response to a range of conditions, in vivo, ex vivo and in vitro.
Developing novel lens materials capable of delivering topical ophthalmic drugs to the eye.
Myopia prevalence, correction and control.
The cellular response to adverse conditions, including contact lens solutions and dry eye
Bacterial binding and biofilm formation on contact lenses and other biomaterials.
Dry eye disease, tear film characterization and tissue assessment.
Contact lenses, spectacles and the use of objective vision assessments to predict subjective satisfaction.
Novel technology, methods and models
BSC biohazard safety level 2, radioactive tracer, GLP, GCP.